Alzheimer

Add Content

• Definition
• Introduction
• Signs & Symptoms
• Research Summary

Presentation Slides

---

Executive Summary

---

Write an executive summary in the form of a blog article on the topic of "Research into Chinese medicine treatment for Alzheimer" summarising the research below and using language that can be easily understood by patients and avoiding medical jargon using a professional and caring tone of voice.

Write an executive summary in the form of a blog article on the topic of "Researched Chinese medicine treatments for Alzheimer" summarising the research below in an objective and easy to understand way, and using language that can be easily understood by patients. Group the article into Chinese medicine treatments first, followed by nutrition and other treatments. Avoid using medical jargon and use a professional and caring tone of voice.

Write me a concise but easy to understand executive summary on the topic of "Chinese medicine treatments for Alzheimer" based on the following research that I will give you. Your summary should be 2 paragraphs long in Australian English spelling and include references to the studies.

A Animal Study published in 2024 in the journal Journal of Ethnopharmacology found that SuanZaoRen Decoction (SZRD) showed therapeutic improvements on Alzheimer's-related neuronal loss, synaptic damage, and ferroptosis, by regulating the DJ-1/Nrf2 signaling pathway. In this study, Liquid chromatography-Mass Spectrometry was utilized to identify the active ingredients from SuanZaoRen Decoction (SZRD). This was then applied to a genetically engineered mouse model (APP/PS1 mouse) for Alzheimer's disease, which was also treated with a ferroptosis inhibitor, Liproxstatin-1, as a control. Various forms of staining, along with immunohistochemistry and transmission electron microscopy were used to evaluate the effects of SZRD on factors such as neuronal loss, synaptic damage, and amyloid-beta deposition. Other methods, like iron staining and an iron assay kit, measured SZRD's impact on ferroptosis. SZRD was found to have alleviated learning and memory impairments in the mouse model, with notable improvements in terms of neuronal loss and degenerated neurons, achieved through the inhibition of amyloid-beta deposits. Additionally, SZRD mitigated synaptic damage and inhibited iron accumulation in the hippocampus - an area significantly affected by Alzheimer's disease. More importantly, SZRD was found to regulate the DJ-1/Nrf2 signaling pathway, affecting protein expression levels and contributing towards an overall decrease in oxidative stress in the hippocampus.

A Network Pharmacology published in 2024 in the journal Hereditas found that The Suanzaoren Decoction seems to address Alzheimer's coupled with diabetes through particular ingredients interacting with specific genes involved in disease and therapeutic response. The study first screened the protein interactors of the main components of Suanzaoren Decoction (SZRD) in the TCMSP database. These protein targets were then cross-referenced with gene candidates influencing both diabetes and Alzheimer's disease, as identified from the Gene Expression Omnibus database. Potentially shared genes were further examined going through a gene-drug-compound-target-disease network and a protein-protein interaction network. The intersecting genes underwent Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses to understand their biological functions and involvement in pathways. In the discussion of the results, a subset of 1,977 diabetes-related genes and 622 Alzheimer’s-related genes were identified, with 97 found to be common among SZRD, diabetes, and Alzheimer’s disease. Specified compounds within SZRD, namely quercetin, kaempferol, licochalcone a, isorhamnetin, formononetin, and naringenin were proposed to be the active ingredients, primarily interacting with genes such as IL6, TNF, IL1B, CXCL8, IL10, CCL2, ICAM1, STAT3, and IL4. The therapeutic effect of SZRD was demonstrated to be involved in cellular responses to drugs, aging processes, and cellular responses to foreign substances, as well as in cancer and cardiovascular pathways. Molecular docking and molecular dynamics simulations revealed high-affinity binding between several SZRD compounds and the proteins CXCL8, IL1B, and CCL2, indicating the therapeutic potential of these interactions.

A Experimental Study published in 2023 in the journal Journal of Applied Toxicology found that Virgin coconut oil shows potential therapeutic promise against Alzheimer's disease by reducing key markers and enhancing neurotransmitter parameters. In this study, the SH-SY5Y cell lines were cultured in its regular growth medium which was then differentiated by reducing its fetal bovine serum content and adding retinoic acid. Further, brain-derived neurotrophic factor was added in unison with retinoic acid, completing the differentiation process by the seventh day. The study groups comprised of a control group, groups that received virgin coconut oil, Aluminum, both or neither, an Alzheimer model group, and a group replicating the Alzheimer model exposed to Aluminum and virgin coconut oil. The measurable aspects in this study included specific indicators of Alzheimer's disease like hyperphosphorylated Tau protein, amyloid beta 1-40 peptide, and amyloid precursor protein, oxidative stress parameters, and neurotransmitter-related parameters. In the results, it was revealed that virgin coconut oil was successful in reducing levels of amyloid beta and hyperphosphorylated Tau protein in the groups. This composition also seemed to decrease oxidative stress levels associated with Alzheimer's disease, delivering improvement in neurotransmitter parameters, which supports the hypothesis that virgin coconut oil can be therapeutic against this progressive neurological disorder.

A Review Article published in 2023 in the journal Journal of the Science of Food and Agriculture found that Carrot and carotene consumption could diminish the risk of a wide range of negative health consequences, including multiple types of cancer. An umbrella review methodology was adopted to identify connections between carrot and carotene intake and various health outcomes. We turned to databases such as Web of Science, PubMed, and Embase to find the needed data. The analysis included the collected evidence from both interventional and observational studies that focused on carrots, carotene, and any related health impact. To estimate the summary effect size for each correlation, both random and fixed effects models were employed. The study reviewed a total of 1329 studies and utilized the data from 30 meta-analyses with 26 health outcomes that fit the eligibility requirements. These featured outcomes related to various types of cancer, fractures, age-related cataract, sunburn, and Alzheimer's disease. The associations were analyzed between the health outcomes and the intake of carrots, intake of carotene, and serum carotene levels.

A Review Article published in 2022 in the journal Molecules found that Green tea's catechins demonstrate therapeutic effects against neurodegenerative diseases via anti-inflammatory, antioxidant actions, and activating diverse brain cellular pathways. The research primarily evaluates the effect of polyphenolic compounds found in green tea, known as catechins, on neurodegenerative diseases. By conducting several interventional and observational studies on humans, the research explores the anti-cancer, anti-obesity, antidiabetic, anti-inflammatory, and neuroprotective properties of these compounds. The biological, pharmacological, antioxidant, and metal chelating abilities of catechins, particularly their influence on different cellular pathways within the brain, are intensively studied. The results elucidate that catechins exhibit multiple neuroprotective effects. Their anti-inflammatory and antioxidant properties help to inhibit excessive production of cytokines, and inflammatory pathways, while also controlling metal ions and free radicals. Researchers have further established that catechins may curb the phosphorylation of the tau protein and aggregation of amyloid beta, both key markers in neurodegenerative diseases. Additionally, these compounds show potential in reducing alpha-synuclein levels and augmenting dopamine levels. Hence, they significantly contribute to the prevention and treatment of neurodegenerative diseases, including Alzheimer's, Parkinson's, multiple sclerosis, and cognitive deficits.

A Network Pharmacology published in 2022 in the journal Natural Product Communications found that Combining traditional Chinese medicine may offer potential therapeutic value in treating both Alzheimer's disease and major depressive disorder simultaneously. Researchers leveraged network pharmacology and molecular docking technology to identify the effect of traditional Chinese medicine and its multitarget components for treating Alzheimer's disease and major depressive disorder. They analyzed 234 TCM prescriptions for major depressive disorder, identifying the top 10 most commonly used herbs, reflecting 198 active ingredients. They then did comparative analysis for prospective ingredient targets related to both disorders. The analysis included exploring common and key targets and representative compounds for effective treatment. The combination of Xiangfu (Cyperi Rhizoma), Gancao (Licorice) and Chaihu (Radix Bupleuri) constituted the major component of representative ingredients that were analyzed. The results yielded the identification of 30 common targets, 9 key targets, and 7 representative compounds relevant to both disorders. Their findings revealed these common targets were essential to regulate multiple pathways linked to both disorders, emphasizing the potential for a cohesive treatment approach. Furthermore, molecular docking studies unveiled the binding affinity of several natural chemicals, including quercetin, kaempferol, β-sitosterol, stigmasterol, isorhamnetin, naringenin, and 8-isopentenyl-kaempferol, with key prospective targets. This suggests that a TCM combination could provide therapeutic advantages in treating both Alzheimer's disease and major depressive disorder.

A Systematic Review published in 2022 in the journal Food Science and Human Wellness found that Bioactive components in green tea have demonstrated potential neuroprotective effects and might play a role in preventing Alzheimer’s disease. In this study, the researchers focused on the potential preventative effects of bioactive compounds, specifically (-)-epigallocatechin-3-gallate, present in tea, on Alzheimer's disease (AD). This interest was based on recognition of the importance of lifestyle-related factors, including diet, in the primary prevention of AD. They compiled and analyzed the findings from various preclinical studies which pointed towards the neuroprotective qualities of these compounds. The results reveal an association between the consumption of green tea and a reduction in the risk of age-related cognitive decline and AD. However, these results do not establish a causal relationship. That is, while people who drink green tea appear to have lower rates of AD, the study cannot confirm that green tea consumption is the reason for this reduced prevalence. The researchers also emphasized that while the preventative effects of green tea were deduced from preclinical (animal) studies, human-based clinical trials yielded unsatisfactory evidence regarding tea's preventive or therapeutic effect on AD.

A Review Article published in 2022 in the journal Journal of Future Foods found that Coconut oil has potential as a nutritional supplement for treating Alzheimer’s disease, due to its medium chain fatty acids and antioxidant properties. The study examined the unique chemical composition of coconut oil that is enriched with medium chain fatty acids, unlike long-chain fatty acids. This distinction matters because these medium chain fatty acids have a specific digestion and metabolism pathway—they bypass the lymphatic system and go straight to the liver through the portal vein. This unique attribute in absorption and metabolism allows these fats to readily form ketone bodies, which are an efficient energy source for brains, especially those experiencing cognitive impairments like Alzheimer's disease. As for the discussion of the results, the findings showed that medium-chain triglycerides in coconut oil get metabolized and absorbed to mitigate the severity of certain physiological risk factors—elevated LDL levels, hypertension, Type 2 diabetes, obesity, and insulin resistance—all risk factors that contribute to the prevalence and incidence of Alzheimer's disease. Additionally, coconut oil contains many polyphenolic compounds that serve as antioxidants, combating oxidative stress and inflammation—in turn, potentially downregulating the etiology of Alzheimer's disease. The antioxidant capacity, however, can vary depending on the processing conditions used in extraction techniques of coconut oil.

A Review Article published in 2022 in the journal Reference Series in Phytochemistry found that Coconut water possesses unique compound profiles that imbue it with a broad spectrum of medical properties, incorporating aspects of nutrition, pharmacology, and disease prevention. The study utilized comprehensive analysis to assess the chemical profile of coconut water, identifying a range of components including phytohormones, enzymes, antioxidant compounds, vitamins, minerals, and phenolic compounds. These components are known to contribute to the water's biological activity and pharmacological effects, thereby enabling a raft of medicinal properties inherent to coconut water. The water was found to feature anti-microbial, anti-bacterial, anti-inflammatory, anti-hypertensive, rejuvenating, hepatoprotective, hypolipidemic, and diuretic properties. An examination of the therapeutic effects of coconut water revealed a significant impact on gastric dysfunction, dysentery, and child malnutrition alongside notable capabilities to manage hypertension. The water was found to promote exercise performance, reduce swelling, dissolve kidney stones, improve kidney function, improve digestion, relieve constipation, reduce the risk of heart disease, lower high blood pressure, and improve cholesterol levels. Consumption of tender coconut water was specifically found to reduce the risk of heart disease, help prevent Alzheimer’s disease pathologies and prevent osteoporosis in experimental animals. The unique nutritional profile of coconut water was also found to provide it with the capacity to balance body chemistry and fight cancer.

A Cohort Study published in 2021 in the journal Aging found that Regular consumption of chocolate relates to lowered risk of death from all causes, cardiovascular disease, and Alzheimer’s disease, particularly in non-smokers. The study traps a population-based cohort of 91,891 participants aged between 55-74 years from across the United States. The consumption of chocolate by these participants is gauged through a food frequency questionnaire. The Cox regression model was utilized to generate risk estimates. In an average monitoring period of 13.5 years, 19,586 all-cause deaths were recorded. In the discussion of the outcomes, the study reveals an inverse correlation between regular chocolate intake and all-cause mortality. This advantage was more significant in those participants who never smoked compared to current or ex-smokers. A stronger inverse association was found for deaths from cardiovascular disease and Alzheimer's disease. A nonlinear dose-response pattern was discovered for all-cause and cardiovascular deaths, with the least risk seen at a chocolate intake of 0.7 and 0.6 servings per week, respectively.

A Review Article published in 2021 in the journal Trends in Food Science & Technology found that Coconut oil has potential therapeutic value in treating Alzheimer's disease by suppressing neuro-inflammation, reversing neurodegeneration, and inhibiting secretion of harmful peptides. The methodology of this study hinges on investigating the impact of coconut oil-derived medium chain fatty acids (MCFAs) on brain glucose metabolism, which is linked to Alzheimer's Disease (AD). These MCFAs rapidly metabolize into ketone bodies, possibly providing alternative energy for cerebral tissue. This research evaluates the recent findings on the role of coconut oil in mitigating AD symptoms, including its dietary effects on reducing neuro-inflammation, reversing neurodegenerative processes, and inhibiting the secretion of amyloid β peptides, which contribute to AD. The results of the investigation reveal a promising correlation between coconut oil and the amelioration of AD symptoms. The effectiveness of coconut oil is believed to be due to its ability in enhancing cell survival pathways, suppressing neuro-inflammation, and reversing neurodegeneration. Coconut oil also proves useful in preventing the secretion of harmful amyloid β peptides, as seen in animal models and human clinical trials. These multi-pronged biochemical effects underline the immense therapeutic potential of coconut oil in treating AD.

A Review Article published in 2021 in the journal Foods found that Fermented soybean products alleviate and possibly prevent neurodegenerative conditions, including Parkinson's and Alzheimer's diseases. The study involved the fermentation of cooked soybeans with specified bacteria and fungi species, a process known to produce a range of bioactive compounds. These unique compounds, which are most often beneficial to health, are contained in fermented soybean products that are a staple in East Asian diets. In analyzing the results, the focus was on the potential of these fermented soy foods and their components in managing neurodegenerative diseases. Notably, the findings suggested a significant preventive and curative effect of these products on such ailments as Alzheimer's and Parkinson's diseases. The paper, therefore, presents fermented soy foods as potentially reliable natural solutions to these neurodegenerative conditions.

A Systematic Review published in 2021 in the journal Annals of Medicine found that The existing evidence, although with low level of confidence, suggests that walnut intake may have a beneficial effect on cognition-related outcomes, including cognitive function, mood, and stroke. The existing evidence, although with low level of confidence, suggests that walnut intake may have a beneficial effect on cognition-related outcomes, including cognitive function, mood, and stroke. Limitations in study design and comparability render the available evidence insufficient to draw a firm conclusion regarding the effects of walnut on cognition in adults. High quality studies and standardized interventions and measurement tools are necessary to determine the role of walnut intake in cognitive health.

A Review Article published in 2020 in the journal International Journal of Molecular Sciences found that Regular coffee consumption, due to its bioactive compounds, may have protective effects against chronic disorders and certain neurodegenerative conditions. The paper evaluates the neuroprotective potential of the main bioactive elements in coffee: caffeine, chlorogenic acid, caffeic acid, trigonelline, kahweol, and cafestol. The analysis is focused on the coffee beverage as a complex mixture of these bioactive compounds. The comprehensive study includes in vitro and in vivo preclinical tests to determine the specific health benefits each of these compounds can offer. The results indicate that regular coffee intake may have defensive effects against a variety of enduring disorders; including cardiovascular disease, type 2 diabetes, obesity, and some forms of cancer. Additionally, an interesting correlation is found between coffee consumption and a lower risk of developing certain neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease, and dementia. The study also highlights that regular coffee intake could possibly lower the risk of stroke. However, the study mentions that the mechanisms enabling these effects are yet to be fully understood.

A Experimental Study published in 2020 in the journal Bioorganic Chemistry found that Green tea polyphenolic compounds, (-)-epigallocatechin (EGC) and (-)-epicatechin-3-gallate (ECG), can diminish harmful Alzheimer's disease linked Aβ aggregates and ameliorate symptoms. Green tea compounds EGC and ECG were tested for their effects on Cu/Zn-induced or self-assembled Aβ aggregation involved in Alzheimer's disease. To do so, a combination of thioflavine T fluorescent spectrometry, inductively coupled plasma mass spectrometry, UV-Vis spectroscopy, transmission electron microscopy, silver staining, immunohistochemistry, and immunofluorescence assays were utilized. Findings indicate that these compounds bind mildly to Cu and Zn and reduce their caused or self-assembled Aβ aggregates. Moreover, these compounds were shown to manage neurotoxicity in mouse neuroblastoma Neuro-2a cells by decreasing the production of reactive oxygen species (ROS). From the findings, the EGC and ECG in green tea showed potential in reducing the toxicity of Aβ oligomers and fibrils which are heavily linked to Alzheimer's disease. Notably, ECG has the ability to traverse the blood-brain barrier and reduce Aβ plaques within the mouse brain, showcasing its potential for neuron protection. This study highlights the potential of green tea - specifically, its polyphenolic compounds - in the prevention or reduction of Alzheimer's disease symptoms.

A Review Article published in 2020 in the journal Frontiers in Aging Neuroscience found that Acupuncture appears to be a promising complementary treatment for Alzheimer's disease, according to findings from systematic reviews and meta-analyses. The study analysed the role of acupuncture as a complementary treatment for Alzheimer's disease by perusing systematic reviews and meta-analyses using data from eight electronic databases. The researchers employed a variety of tools such as the Assessing the Methodological Quality of Systematic Reviews 2, Risk of Bias in Systematic Reviews tool, Preferred Reporting Items for Systematic Reviews and Meta-Analyses, and the Grading of Recommendations, Assessment, Development, and Evaluation to determine the quality of methodology, risk of potential bias, and quality of the evidence. A total of eleven systematic reviews and meta-analyses met the necessary criteria for inclusion in this study. The results, despite indicating that acupuncture may show promise as a complementary treatment for Alzheimer's disease, all rated critically low in quality when assessed with the tools employed. Some methodological weaknesses remained, particularly pertaining to the protocol and registration, search strategy, risk of bias, additional analyses, and funding. Only a small portion of the reviews exhibited a low risk of bias. There was no high-quality evidence found, but moderate-quality evidence was provided for seven outcomes. The risk of bias in the original trials seemed more prevalent than inconsistency, imprecision, and publication bias.

A Systematic Review published in 2020 in the journal BMC Complementary Medicine and Therapies found that Danggui Shaoyao San may regulate multiple biological pathways related to Alzheimer's disease pathogenesis, such as the oxidative stress and inflammatory reaction processes. We constructed a global drug-target network of Danggui Shaoyao San (DSS) consisting 937 unique compounds and 490 targets by incorporating experimental and computationally predicted drug–target interactions (DTIs). Multi-level systems pharmacology analyses revealed that DSS may regulate multiple biological pathways related to AD pathogenesis, such as the oxidative stress and inflammatory reaction processes. We further conducted a network-based statistical model, drug-likeness analysis, human intestinal absorption (HIA) and blood-brain barrier (BBB) penetration prediction to uncover the key ani-AD ingredients in DSS. Finally, we highlighted 9 key ingredients and validated their synergistic role against AD through a subnetwork.

A Systematic Review published in 2020 in the journal Frontiers in Aging Neuroscience found that Acupuncture plus drug therapy may have a more beneficial effect for Alzheimer's disease patients than drug therapy alone on general cognitive function in the short and medium term and on Activities of Daily Living scores in the medium term. 30 RCTs (2,045 patients) were included in this review. The main finding of our review suggests acupuncture plus drug therapy may be more beneficial for AD patients than drug therapy alone in the areas of general cognitive function in the short term and medium term, and ADL skills in the medium term. However, acupuncture alone may not have superior effects when compared with drug therapy on general cognitive function, ADL skills, or incidence of adverse events. Duration of treatment may not modify the effect of acupuncture in comparison with drug therapy.

A Review Article published in 2019 in the journal Revue Neurologique found that The Mediterranean diet, especially the high consumption of extra-virgin olive oil, significantly reduces the risks of vascular diseases and Alzheimer's. The research has been based on a plethora of observational epidemiological studies, local population experiences, meta-analyses of epidemiologic data, and experimental studies, all converging to the connection between the Mediterranean diet and a reduced prevalence of different ailments. The study scopes extend over long periods, such as the Italian-American experience from 1935 to 1965, or the Seven Countries Study spanning four decades from 1960 to 2000. Another significant evidence base is the French Three-City Study, which followed participants for ten years from 2000 to 2010. Apart from human trials, the article includes results from experimental animal models, specifically concerning late-onset Alzheimer disease. The findings showcase a consistent trend linking reduction in vascular diseases, obesity, arthritis, cancer, cognitive decline, and specifically Alzheimer's disease with increased adherence to a Mediterranean dietary pattern, particularly high intake of extra-virgin olive oil. Certain dietary components such as fruits, seeds, legumes, and vegetables contribute to the benefits. However, olive oil stands out as the chief dietary fat in Mediterranean countries. It provides plentiful monounsaturated fatty acids, beneficial polyphenols, and other antioxidants, which play a crucial part in these health benefits. The most striking discovery is extra-virgin olive oil's potential to mitigate the effects of adverse vascular factors, indicating a promising approach to preventing late-onset Alzheimer's disease.

A Network Pharmacology published in 2019 in the journal Biomedicine & Pharmacotherapy found that Chaihu Shugan San, a traditional Chinese medicine, can lessen Alzheimer's disease cognitive dysfunction through multiple biological targets and pathways of action. In exploring the effects of Chaihu Shugan San (CSS) on Alzheimer's Disease, the researchers initially identified 152 active compounds in CSS, 520 predicted biological targets and 160 Alzheimer's disease-related targets. They then constructed several networks, including herb-compound-target network, which outlines connections between the medicinal herbs and their linked impacts, an Alzheimer's disease-target network, and a CSS potential target-Alzheimer's target network. A central network topological analysis was used to discern 60 key targets that are largely contributive to CSS's beneficial effects on Alzheimer's Disease. These targets were majorly identified as nuclear or cytoplasmic proteins with a molecular function of protein binding. In discussing the experiment results, the researchers found that CSS treatment could alleviate neural cell death caused by Aβ (amyloid beta, a peptide believed to contribute to Alzheimer's Disease). They noticed a drop in apoptotic, or self-destroying, cell count in differentiated PC12 cells that underwent CSS treatment. Subsequently, they observed an upsurge in the phosphorylation of a protein, Akt, and a downswing in the expression of another protein, Bax, indicating that the Akt signaling pathway plays a vital part in the CSS's protective impact against neural cell destruction.

A Systematic Review published in 2019 in the journal Current Medical Science found that Acupuncture yielded positive results for Alzheimer's Disease as determined via clinical efficacy rate, Mini-Mental State Examination score, Ability of Daily Living Scale score and Alzheimer’s Disease Assessment Scale-Cognition score. Eight databases were searched for articles published up to and including July 2017, and 13 studies fulfilling the inclusion criteria were identified. The main outcomes assessed were clinical efficacy rate, Mini-Mental State Examination score, Ability of Daily Living Scale score, Alzheimer’s Disease Assessment Scale-Cognition score, Hasegawa’s Dementia Scale (HDS) score, and adverse events. The methodological quality of the articles was assessed using Cochrane’s risk of bias. All the studies compared the efficacy of acupuncture with that of medication, and were published in Chinese journals. Meta-analysis revealed that acupuncture yielded positive results as determined via all the indexes scored except the HDS. Only one of the studies reported adverse events associated with acupuncture and medication. The rate of adverse events in the medication group was 13%. In most of the studies assessed in the current meta-analysis, acupuncture alone was better than conventional western medicines for the treatment of AD.

A Review Article published in 2019 in the journal Frontiers in Psychiatry found that Evidence indicates that acupuncture treatment may be of benefit in several neuropsychiatric disorders, including depression, anxiety, schizophrenia, and Alzheimer's Disease. The pathophysiology of these disorders may be associated with glutamate dysregulation, marked by a high rate of glutamate release and elevated expression of glutamate receptors and glutamate transporters in the CNS. The ability of acupuncture stimulation to modulate glutamate receptor and EAAT expression suggests that the treatment effects of acupuncture are underpinned by its intervention in the dysregulated glutamate system. Further preclinical and clinical studies are needed to clarify the possible mechanisms of acupuncture in these neuropsychiatric disorders and to establish protocols for treatment guidelines.

A Review Article published in 2019 in the journal American Journal of Therapeutics found that Mg is essential in the metabolism of vitamin D, and taking large doses of vitamin D can induce severe depletion of Mg. Adequate magnesium supplementation should be considered as an important aspect of vitamin D therapy. Vitamin D screening assay is readily available, but the reported lower limit of the normal range is totally inadequate for disease prevention. Based on the epidemiologic studies, ∼75% of all adults worldwide have serum 25(OH)D levels of <30 ng/mL. Because of the recent increase in global awareness, vitamin D supplementation has become a common practice, but Mg deficiency still remains unaddressed. Screening for chronic magnesium deficiency is difficult because a normal serum level may still be associated with moderate to severe deficiency. To date, there is no simple and accurate laboratory test to determine the total body magnesium status in humans.

A Review Article published in 2015 in the journal Aging & Disease found that The widely-used herbal formula Dang Gui Shao Yao San can alleviate cognitive dysfunction in Alzheimer's disease by improving the function of various central nervous systems. The study examines the impact of the herbal formula Danggui-Shaoyao-San (DSS), commonly used for treating various gynecological conditions, on neurological disorders, particularly Alzheimer's disease. DSS has been observed to exert beneficial effects on the central monoamine neurotransmitter systems, improving the functionality of dopaminergic, adrenergic, and serotonergic nervous systems. Furthermore, it has shown a mitigating effect on the dysfunction of the central cholinergic nervous system and a scopolamine-induced decrease in Acetylcholine levels. In the discussion of results, it was discerned that DSS demonstrates anti-inflammatory and antioxidant activities, while also reducing cell apoptosis in the hippocampus. Additionally, it's suggested DSS could play a role in moderating free radical-mediated neurological diseases. Of major significance was the observation that DSS can potentially alleviate cognitive dysfunction in Alzheimer's patients, positioning it as a potentially effective treatment for this disease.

A Systematic Review published in 2015 in the journal Medicine found that Acupuncture has been found potentially more effective than drugs in improving cognitive function and daily life in Alzheimer's disease patients, while also demonstrating safety. The research methodology involved a comprehensive exploration of multiple databases including Central Register of Controlled Trials, PubMed, MEDLINE, Embase, PsycINFO, and various Chinese platforms from their inception to June 2014. The focus was on Randomized Controlled Trials where Alzheimer's disease patients received treatment either solely through acupuncture or in conjunction with one kind of drug. Data was independently extracted by two authors, and results concerning adverse reactions related to acupuncture were documented. In analyzing the results of ten trials incorporating a total of 585 participants, it was clear that acupuncture demonstrated advantages over drugs alone, particularly in terms of improving scores on the Mini Mental State Examination scale. Additionally, evidence suggested that integrating acupuncture with the Alzheimer drug Donepezil was more effective in improving the same scale score when contrasted with using Donepezil as a sole treatment method. Adverse reactions linked to acupuncture were reported in only two trials out of 141, pointing to a low incidence of complications related to the procedure.

A Review Article published in 2014 in the journal Drug Design, Development and Therapy found that A mixture of active polysaccharides from Goji berries have shown multiple pharmacological activities, including anti-aging, antioxidative, anti-fatigue, anticancer, anti-diabetic, anti-viral, hepatoprotective, cardioprotective, neuroprotective, hypolipidemic, radioprotective, anti-osteoporosis, anti-inflammatory, and immunomodulating effects. The mechanisms for these beneficial effects are multifaceted, involving a number of signaling molecules and pathways. A better understanding of how LBPs act on these signaling pathways and molecules can improve our knowledge on glycobiology. Further studies using systems pharmacology approaches such as proteomic and metabolomic analysis are needed to uncover the molecular target networks of LBPs. Despite the importance of Goji in the traditional Chinese medicine and increased popularity in Western countries, clinical safety data on LBPs are sparse. A safe and optimal use of herbal medicines like LBPs requires a full understanding of their pharmacokinetics, side effects, and mechanisms of action. The dose–response and dose–toxicity relationships of LBPs should be established in animal and human studies. It is essential to develop new formulations to ensure the maximum efficacy and effectiveness and minimum side effects of LBP-related health products.

A Review Article published in 2013 in the journal British Journal of Clinical Pharmacology found that Cocoa and chocolate, rich in antioxidant molecules like epicatechin, enhance brain health, stimulate brain perfusion, and reduce the risk of Alzheimer's disease and stroke. The study involved taking a comprehensive look at the substances contained in cocoa powder and chocolate, their absorption into the brain, and their resulting stimulatory effects on multiple areas of the brain, particularly those connected to comprehension and memory. It also delved into the beneficial effects of epicatechin, a flavonoid found abundantly in cocoa and chocolate, which showed improvements in cognition in both animals and humans. Interestingly, the research showed that the consumption of chocolate could induce mood enhancement, elaborating on its common consumption during times of emotional stress. The study further investigated flavonoids' preservation of cognitive abilities in rats during aging, noting the reduced risk of developing Alzheimer's disease and the decreased likelihood of stroke in humans, demonstrating their wider effects beyond just mood enhancement. The research then looked into flavonoids' interactions within the various signaling pathways related to proteins and lipids in the brain, shedding light on how they inhibit neuron death from neurotoxic elements like oxygen radicals, all while promoting neuron survival and synaptic plasticity. The overall intent of the research was to gather and examine the available data regarding the effects of cocoa and chocolate on brain health and cognitive capacities.

A Experimental Study published in 2007 in the journal Mycobiology found that Tremella fuciformis, a mushroom, shows potential as a protective agent against neurodegenerative diseases like Alzheimer's by promoting cell growth and reducing toxicity. The methodology involved testing the neurotrophic effects of Tremella fuciformis, a mushroom, using a hot water extract of it. This testing was done by utilizing microscopic monitoring of its ability to encourage neurite outgrowth in PC12h cells, essentially examining the mushroom's ability to stimulate nerve growth. The researchers compared the effectiveness of the extract to other natural substances that had previously been studied in promoting nerve growth. In the discussion of results, the study demonstrated that the hot water extract of T. fuciformis was highly effective at promoting neurite outgrowth in PC12h cells. This effectiveness outperformed other natural substances in previous studies. Moreover, when the cells were treated with T. fuciformis extract before being exposed to a β-amyloid peptide treatment (which is associated with Alzheimer's disease), the extract significantly reduced the toxicity. This suggests the potential application of T. fuciformis as a preventative measure in counteracting neurodegenerative diseases such as Alzheimer's.

Moderation Tools

---

Topic